2023. Efficacy and Safety of Sofosbuvir and Ribavirin in Treatment of Chronic Hepatitis C Infection G3 of Multi-Transfused Children Aged 4 To 12 Years; A Single Center Study . Medical Forum Monthly. 34, 7 (Aug. 2023). DOI:https://doi.org/10.60110/medforum.340737.